ATLANTIC: Pre-hospital ticagrelor did not benefit reperfusion in STEMI

September 1, 2014 9:21 AM

13 0

BARCELONA, Spain — Although safe, pre-hospital administration of ticagrelor did not improve pre-PCI coronary reperfusion in patients with acute STEMI when compared with in-hospital administration of the drug, according to data presented here at ESC Congress.

“[Pre-hospital ticagrelor administration] may, however, reduce the risk of stent thrombosis after PCI,” Gilles Montalescot, MD, PhD, of the Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, said at a press conference.

Read more

To category page